Vaxinia..all is well
These milestones are indicative of the study’s progression on schedule, with critical data being produced for the eventual publication of outcomes from the trial.
Add the $12.6 million R &D grant to the $151.5 million already banked, and then add even more R&D in years to come, and you begin to see the powerhouse IMU is set to become when all 9 clinical trials are underway..
A mini Genentech Roche anyone?
Best of luck to ALTH's
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
